Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T06:32:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added announcing a transition from using “Artificial Intelligence” to “Super Intelligence” in some federal-agency content.
    Difference
    0.5%
    Check dated 2026-10-25T06:58:16.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T05:46:22.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T08:31:25.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The history now lists a new version (v3.7.0) and removes the previous (v3.6.6), representing an update to the recorded history rather than a change to the trial data.
    Difference
    0.1%
    Check dated 2026-09-20T03:26:18.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study history, replacing the prior v3.6.5 entry in the visible history. No study data or participant-facing content is affected.
    Difference
    0.1%
    Check dated 2026-08-29T23:49:35.000Z thumbnail image

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.